Biogen Pharmachem Industries Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Biogen Pharmachem Industries Ltd. on BSE

Search Inside the pdf :

Biogen Pharmachem Industries Ltd.

23 May 2025

Result

Biogen Pharmachem Industries Ltd - 531752 - Regulations 30, 33 And Other Applicable Provisions Of The …

BSE India

PFA

pdf

	Mar 2025	Dec 2024	Mar 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	1.35	0.23	0.78	487.0%	73.1%
Operating Profit Qtr	-0.17	-0.54	-0.04	68.5%	-325.0%
Net Profit Qtr	1.18	-0.31	0.74	480.6%	59.5%
Earning Per Share Adjusted latest Qtr	0.02	-0.00	0.01	-	100.0%

* Standalone data

Detailed Results

Biogen Pharmachem Industries Ltd.

23 May 2025

Board Meeting

Biogen Pharmachem Industries Ltd - 531752 - Board Meeting Outcome for Outcome Of The Board Meeting …

BSE India

This is to inform you that Outcome of the Board Meeting of the Company held on Friday 23rd May, 2025 in accordance with SEBl (Listing Obligations and Disclosures Requirements) Regulations, 2015, has been approved by the Board of Directors of the Company and taken on record inter-alia the following items; 1.) Consideration and Approval of Audited Financial Result for the Year ended 31st March, 2025. 2.) Independent Audit Report in pursuance with Regulation 33 of SEBI (LODR) Regulations, 2015 for the F.Y. 31st March, 2025. Further, we hereby declare that the Auditor of the Company has issued the Audit report under the Companies Act, 2013 and financial results as prepared under SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015 for the financial year ended on March 31, 2025 with unmodified opinion. The board meeting commenced on 04:45 PM and concluded on 05:30PM Request you to kindly take on record the same. Thanking You.

pdf

Biogen Pharmachem Industries Ltd.

12 May 2025

Board Meeting

Biogen Pharmachem Industries Ltd - 531752 - Board Meeting Intimation for Compliance Of Regulation 29 And …

BSE India

Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2025 ,inter alia, to consider and approve PFA

pdf

Biogen Pharmachem Industries Ltd.

08 May 2025

Company Update

Biogen Pharmachem Industries Ltd - 531752 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

PFA

pdf

Biogen Pharmachem Industries Ltd.

15 Apr 2025

Corp. Note

Biogen Pharmachem Industries Ltd - 531752 - Board Meeting Outcome for Outcome Of Board Meeting Held …

BSE India

This is to Inform you that at the Meeting of the Board of Directors of the Company held today on Tuesday, 15th April 2025 It has further informed that all final call is called up on 08.04.2025 and so now warrants are fully paid up and converted into equity shares of the Company on the preferential basis and allotted as the pdf attached. The meeting commenced at 03:30 P.M. and concluded at 04:00 P.M. : Please take this on your record. This is for your information Thanking You.

pdf

Biogen Pharmachem Industries Ltd.

08 Apr 2025

Corp. Note

Biogen Pharmachem Industries Ltd - 531752 - Board Meeting Outcome for Outcome Of Board Meeting Held …

BSE India

PFA

pdf

Biogen Pharmachem Industries Ltd.

07 Apr 2025

Company Update

Biogen Pharmachem Industries Ltd - 531752 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, …

BSE India

PFA

pdf

Biogen Pharmachem Industries Ltd.

27 Mar 2025

Corp. Note

Biogen Pharmachem Industries Ltd - 531752 - Board Meeting Outcome for Outcome Of Board Meeting Held …

BSE India

We wish to inform that the Board of Directors in their meeting held today, i.e., March 27, 2025, inter-alia, considered and approved the following items: 1. Allotment of 25,00,00,000 (Twenty-Five Crore Only) equity share warrants to non-promoters on Preferential Basis at an issue price of Rs. 1.68/- (Rupees one and sixty-eight paise) each upon receipt of other 5% of the total consideration. The above said allotments have been made in accordance with the terms mentioned in the notice of Postal Ballot dated 13.08.2024 and in compliance with the applicable provisions of the Companies Act, 2013 and SEBI (ICDR) Regulations. Disclosures pursuant to the Regulation 30 of the SEBI (LODR) Regulations read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 is attached as Annexure A. The meeting commenced at 05:00 P.M. and concluded at 05:40 P.M. This is for your information. Thanking You.

pdf

Biogen Pharmachem Industries Ltd.

21 Mar 2025, 05:16PM

SAST

Biogen Pharmachem Industries Ltd - 531752 - Closure of Trading Window

BSE India

PFA

pdf

Biogen Pharmachem Industries Ltd.

21 Mar 2025, 04:40PM

Corp. Note

Biogen Pharmachem Industries Ltd - 531752 - Board Meeting Outcome for Outcome Of Board Meeting Held …

BSE India

We wish to inform that the Board of Directors in their meeting held today, i.e., March 21, 2025, inter-alia, considered and approved the following items: 1. Allotment of 25,00,00,000 (Twenty-Five Crore Only) equity share warrants to non-promoters on Preferential Basis at an issue price of Rs. 1.68/- (Rupees one and sixty-eight paise) each upon receipt of other 5% of the total consideration. The above said allotments have been made in accordance with the terms mentioned in the notice of Postal Ballot dated 13.08.2024 and in compliance with the applicable provisions of the Companies Act, 2013 and SEBI (ICDR) Regulations. Disclosures pursuant to the Regulation 30 of the SEBI (LODR) Regulations read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 is attached as Annexure A. The meeting commenced at 04:00 P.M. and concluded at 04:30 P.M. This is for your information.

pdf

Is Sun Techno Overseas Ltd. worth buying?

102 Votes:

Buy 73.53%

Sell 11.76%

Hold 14.71%